436 research outputs found
Aaron Spell Bankruptcy Declaration, 1842
Declaration of bankruptcy for A. Spell 20 February 1842, signed by District Judge Samuel J. Gholson, Jackson, Mississippi. Spell first filed for bankruptcy on 8 November 1842.https://scholarsjunction.msstate.edu/mss-spell-papers/1014/thumbnail.jp
d-Fold Partition Diamonds
In this work we introduce new combinatorial objects called --fold
partition diamonds, which generalize both the classical partition function and
the partition diamonds of Andrews, Paule and Riese, and we set to be
their counting function. We also consider the Schmidt type --fold partition
diamonds, which have counting function Using partition analysis, we
then find the generating function for both, and connect the generating
functions to Eulerian polynomials. This allows
us to develop elementary proofs of infinitely many Ramanujan--like congruences
satisfied by for various values of , including the following
family: for all and all Comment: 16 pages, 3 figures; v2: added a new result concerning Eulerian
polynomials and several subsequent congruences for , and corrected
a mistake in the proof of Proposition 1.
Numerical Simulation of Bolide Entry with Ground Footprint Prediction
As they decelerate through the atmosphere, meteors deposit mass, momentum and energy into the surrounding air at tremendous rates. Trauma from the entry of such bolides produces strong blast waves that can propagate hundreds of kilometers and cause substantial terrestrial damage even when no ground impact occurs. We present a new simulation technique for airburst blast prediction using a fully-conservative, Cartesian mesh, finite-volume solver and investigate the ability of this method to model far- field propagation over hundreds of kilometers. The work develops mathematical models for the deposition of mass, momentum and energy into the atmosphere and presents verification and validation through canonical problems and the comparison of surface overpressures, and blast arrival times with actual results in the literature for known bolides. The discussion also examines the effects of various approximations to the physics of bolide entry that can substantially decrease the computational expense of these simulations. We present parametric studies to quantify the influence of entry-angle, burst-height and other parameters on the ground footprint of the airburst, and these values are related to predictions from analytic and handbook-methods
Dengue Virus Infection of Aedes aegypti Requires a Putative Cysteine Rich Venom Protein
Citation: Londono-Renteria, B., Troupin, A., Conway, M. J., Vesely, D., Ledizet, M., Roundy, C. M., . . . Colpitts, T. M. (2015). Dengue Virus Infection of Aedes aegypti Requires a Putative Cysteine Rich Venom Protein. Plos Pathogens, 11(10), 23. doi:10.1371/journal.ppat.1005202Dengue virus (DENV) is a mosquito-borne flavivirus that causes serious human disease and mortality worldwide. There is no specific antiviral therapy or vaccine for DENV infection. Alterations in gene expression during DENV infection of the mosquito and the impact of these changes on virus infection are important events to investigate in hopes of creating new treatments and vaccines. We previously identified 203 genes that were >= 5-fold differentially upregulated during flavivirus infection of the mosquito. Here, we examined the impact of silencing 100 of the most highly upregulated gene targets on DENV infection in its mosquito vector. We identified 20 genes that reduced DENV infection by at least 60% when silenced. We focused on one gene, a putative cysteine rich venom protein (SeqID AAEL000379; CRVP379), whose silencing significantly reduced DENV infection in Aedes aegypti cells. Here, we examine the requirement for CRVP379 during DENV infection of the mosquito and investigate the mechanisms surrounding this phenomenon. We also show that blocking CRVP379 protein with either RNAi or specific antisera inhibits DENV infection in Aedes aegypti. This work identifies a novel mosquito gene target for controlling DENV infection in mosquitoes that may also be used to develop broad preventative and therapeutic measures for multiple flaviviruses
An Electronic Pre-Exposure Prophylaxis Initiation and Maintenance Home Care System for Nonurban Young Men Who Have Sex With Men: Protocol for a Randomized Controlled Trial
BACKGROUND: Pre-exposure prophylaxis (PrEP) is highly efficacious for preventing HIV but has not yet been brought to scale among at-risk persons. In several clinical trials in urban areas, technology-based interventions have shown a positive impact on PrEP adherence. In rural and small-town areas in the United States, which often do not have geographically proximal access to PrEP providers, additional support may be needed. This may be particularly true for younger persons who are more likely to face multiple barriers to accessing PrEP services. Home-based care, accomplished through a tailored mobile phone app, specimen self-collection (SSC), and interactive video consultations, could increase both PrEP initiation and persistence in care. OBJECTIVE: The goal of this study is to assess the initiation and persistence in PrEP care for those randomized to a home-care intervention (electronic PrEP, ePrEP) relative to those assigned to the standard of care (control) condition. We will conduct additional assessments, including quantitative and qualitative analyses, to contextualize trial results and facilitate scale-up. METHODS: This 2-arm, randomized controlled trial will enroll young men who have sex with men (YMSM) aged between 18 and 24 years from rural areas of Georgia, Mississippi, and North Carolina. The trial will seek to recruit a diverse sample, targeting 50% participation among highly impacted groups of black or Latino men who have sex with men. Intervention participants will receive a study app that incorporates a messaging platform, a scheduling and milestone-based tracking system for PrEP care progress, electronic behavioral surveys, and interactive video consultations with a clinician. Complemented by SSC kits mailed to laboratories for standard PrEP-related monitoring, the ePrEP system will allow participants to access PrEP care without leaving their homes. YMSM randomized to the control condition will receive a listing of nearest local PrEP providers to receive standard PrEP care. Both groups will complete quarterly electronic surveys. The primary outcome, assessed at 6 and 12 months after randomization, will be the difference in the proportion of intervention versus control participants that achieve protective levels of the active metabolite of oral PrEP (tenofovir diphosphate in dried blood spots). RESULTS: Enrollment will begin in May 2019, with study completion in 2022. CONCLUSIONS: This trial will determine whether home PrEP care provided through an app-based platform is an efficacious means of expanding access to PrEP care for a diverse group of YMSM in rural and small-town areas of the United States
- …
